RB PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
RB PHARMA
Largest movements
- Cash -€106,444
down €106,444 (-68.3%), from €155,903 to €49,458
mainly Investment in fixed assets (net) (-€166,506) and Receivables within one year (-€83,288)
- Receivables within one year +€83,288
up €83,288 (+4663.7%), from €1,786 to €85,074
of which Trade receivables: +€83,033
- Financial fixed assets +€81,632
up €81,632 (+141.7%), from €57,605 to €139,237
- Tangible fixed assets +€49,867
up €49,867 (+75.4%), from €66,159 to €116,026
of which Assets under construction and advance payments: +€29,500
- Receivables after one year -€16,284
no longer reported in 2025 (was €16,284)
- Other debts +€97,488
up €97,488 (+93.7%), from €104,078 to €201,566
- Profit (loss) carried forward -€24,303
down €24,303 (-22.4%), from €108,634 to €84,331
- Trade debts +€9,256
up €9,256 (+217.1%), from €4,263 to €13,519
- Tax, wage and social debts +€7,868
up €7,868 (+28.9%), from €27,187 to €35,055
of which Remuneration and social security: +€21,978
- Turnover +€381,827
new in 2025: €381,827
- Purchases and services +€198,008
new in 2025: €198,008
- Staff costs +€179,957
new in 2025: €179,957
- Gross operating margin +€167,906
up €167,906 (+683.1%), from €24,581 to €192,487
- Depreciation +€35,007
new in 2025: €35,007
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €300,972 | €391,281 | +€90,309 | +30.0% |
| Fixed assets | 21/28 | €123,764 | €255,263 | +€131,499 | +106.3% |
| Tangible fixed assets | 22/27 | €66,159 | €116,026 | +€49,867 | +75.4% |
| Land and buildings | 22 | €9,653 | €9,010 | -€644 | -6.7% |
| Furniture and vehicles | 24 | €47,057 | €73,124 | +€26,068 | +55.4% |
| Leasing and similar rights | 25 | €1,853 | - | -€1,853 | |
| Other tangible fixed assets | 26 | €7,596 | €4,392 | -€3,204 | -42.2% |
| Assets under construction and advance payments | 27 | - | €29,500 | +€29,500 | |
| Financial fixed assets | 28 | €57,605 | €139,237 | +€81,632 | +141.7% |
| Current assets | 29/58 | €177,208 | €136,018 | -€41,190 | -23.2% |
| Amounts receivable after more than one year | 29 | €16,284 | - | -€16,284 | |
| Trade receivables | 290 | €16,284 | - | -€16,284 | |
| Amounts receivable within one year | 40/41 | €1,786 | €85,074 | +€83,288 | +4663.7% |
| Trade receivables | 40 | - | €83,033 | +€83,033 | |
| Other amounts receivable | 41 | €1,786 | €2,041 | +€256 | +14.3% |
| Cash at bank and in hand | 54/58 | €155,903 | €49,458 | -€106,444 | -68.3% |
| Deferred charges and accrued income | 490/1 | €3,236 | €1,486 | -€1,750 | -54.1% |
| Total equity and liabilities | 10/49 | €300,972 | €391,281 | +€90,309 | +30.0% |
| Equity | 10/15 | €165,444 | €141,141 | -€24,303 | -14.7% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Reserves | 13 | €50,610 | €50,610 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Tax-exempt reserves | 132 | €18,750 | €18,750 | = | 0.0% |
| Distributable reserves | 133 | €30,000 | €30,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €108,634 | €84,331 | -€24,303 | -22.4% |
| Amounts payable | 17/49 | €135,528 | €250,140 | +€114,612 | +84.6% |
| Amounts payable within one year | 42/48 | €135,528 | €250,140 | +€114,612 | +84.6% |
| Trade debts | 44 | €4,263 | €13,519 | +€9,256 | +217.1% |
| Suppliers | 440/4 | €4,263 | €13,519 | +€9,256 | +217.1% |
| Taxes, remuneration and social security | 45 | €27,187 | €35,055 | +€7,868 | +28.9% |
| Taxes | 450/3 | €19,735 | €5,625 | -€14,110 | -71.5% |
| Remuneration and social security | 454/9 | €7,452 | €29,430 | +€21,978 | +294.9% |
| Other amounts payable | 47/48 | €104,078 | €201,566 | +€97,488 | +93.7% |
| Turnover | 70 | - | €381,827 | +€381,827 | |
| Goods, raw materials, services and sundry goods | 60/61 | - | €198,008 | +€198,008 | |
| Remuneration, social security and pensions | 62 | - | €179,957 | +€179,957 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €35,007 | +€35,007 | |
| Other operating charges | 640/8 | - | €522 | +€522 | |
| Gross operating margin | 9900 | €24,581 | €192,487 | +€167,906 | +683.1% |
| Operating profit (loss) | 9901 | €24,581 | -€23,000 | -€47,580 | |
| Financial charges | 65/66B | €453 | €1,303 | +€849 | +187.3% |
| Recurring financial charges | 65 | €453 | €1,303 | +€849 | +187.3% |
| Profit (loss) for the period before taxes | 9903 | €24,127 | -€24,303 | -€48,430 | |
| Income taxes | 67/77 | €9,629 | - | -€9,629 | |
| Profit (loss) for the period | 9904 | €14,498 | -€24,303 | -€38,801 | |
| Profit (loss) for the period to be appropriated | 9905 | €14,498 | -€24,303 | -€38,801 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.